Skip to main content
Top
Published in: Annals of Surgical Oncology 4/2008

01-04-2008 | Melanomas

Compliance with Melanoma Treatment Guidelines in a Community Teaching Hospital: Time Trends and Other Variables

Authors: Jennifer L. Erickson, MD, Josè M. Velasco, MD, Tina J. Hieken, MD

Published in: Annals of Surgical Oncology | Issue 4/2008

Login to get access

Abstract

Background

Variation in the surgical treatment of melanoma occurs despite efforts to standardize care. This may lead to morbidity, inaccurate staging, and poor outcomes, or it may be cost ineffective. The purpose of our study was to evaluate our institutional compliance with National Comprehensive Cancer Network (NCCN) melanoma treatment guidelines.

Methods

We studied 252 clinically node-negative melanoma patients identified from our cancer registry. Treatment data were confirmed by individual review of pathology and operative reports.

Results

Documented margins of excision conformed to NCCN guidelines in 87% of Tis–T1 tumors and 60% of T2–T4 tumors. Lymph node staging was performed in 11% of T1a, 64% of T1b, 74% of T2, 63% of T3, and 47% of T4 patients. Treatment by a surgical oncologist achieved margin and lymph node compliance in 95% and 92% of cases versus other practitioners in 38% and 67%, respectively (P < .0001). Documented compliance with margin guidelines improved from 46% to 73% for the years 1995 to 1999 versus 2000 to 2004 (P < .0001) and for lymph node staging and treatment from 74% to 84% (P = .04). Other factors associated with greater adherence to NCCN guidelines were patient age <80 years, upper extremity tumors, and thinner tumors (all P < .05).

Conclusions

Our data suggest that our compliance with NCCN melanoma treatment guidelines was suboptimal. Treatment directed by a surgical oncologist showed the highest rate of adherence to national standards. Further investigation is needed to determine the effect of this on patient outcomes and how best to provide high-quality care to the greatest number of melanoma patients.
Literature
1.
go back to reference Jamal A, Siegel R, Ward E, et al. Cancer Statistics, 2007. CA Cancer J Clin 2007;57:43–66CrossRef Jamal A, Siegel R, Ward E, et al. Cancer Statistics, 2007. CA Cancer J Clin 2007;57:43–66CrossRef
2.
go back to reference Veronesi U, Cascinelli N. Narrow excision (1-cm margin): a safe procedure for thin cutaneous melanoma. Arch Surg 1991;126:438–41PubMed Veronesi U, Cascinelli N. Narrow excision (1-cm margin): a safe procedure for thin cutaneous melanoma. Arch Surg 1991;126:438–41PubMed
3.
go back to reference Cohn-Cedermark G, Rutqvist LE, Andersson R, et al. Long term results of a randomized study by the Swedish Melanoma Study Group on 2-cm versus 5-cm resection margins for patients with cutaneous melanoma with a tumor thickness of 0.8–2.0 mm. Cancer 2000;89:1495–501PubMedCrossRef Cohn-Cedermark G, Rutqvist LE, Andersson R, et al. Long term results of a randomized study by the Swedish Melanoma Study Group on 2-cm versus 5-cm resection margins for patients with cutaneous melanoma with a tumor thickness of 0.8–2.0 mm. Cancer 2000;89:1495–501PubMedCrossRef
4.
go back to reference Balch CM, Soong SJ, Smith T, et al. Long-term results of a prospective surgical trial comparing 2 cm vs. 4 cm excision margins for 740 patients with 1–4 mm melanomas. Ann Surg Oncol 2001;8:101–8PubMed Balch CM, Soong SJ, Smith T, et al. Long-term results of a prospective surgical trial comparing 2 cm vs. 4 cm excision margins for 740 patients with 1–4 mm melanomas. Ann Surg Oncol 2001;8:101–8PubMed
5.
go back to reference Khayat D, Rixe O, Martin G, et al. Surgical margins in cutaneous melanoma (2 cm versus 5 cm for lesions measuring less than 2.1-mm thick): long-term results of a large European multicentric phase III study. Cancer 2003;97:1941–6PubMedCrossRef Khayat D, Rixe O, Martin G, et al. Surgical margins in cutaneous melanoma (2 cm versus 5 cm for lesions measuring less than 2.1-mm thick): long-term results of a large European multicentric phase III study. Cancer 2003;97:1941–6PubMedCrossRef
6.
go back to reference Thomas JM, Newton-Bishop J, A’Hern R, et al. Excision margins in high-risk malignant melanoma. N Engl J Med 2004;350:757–66PubMedCrossRef Thomas JM, Newton-Bishop J, A’Hern R, et al. Excision margins in high-risk malignant melanoma. N Engl J Med 2004;350:757–66PubMedCrossRef
7.
go back to reference McKinnon JG, Starritt EC, Scolyer RA, et al. Histopathologic excision margin affects local recurrence rate: analysis of 2681 patients with melanomas ≤2 mm thick. Ann Surg 2005;241:326–33PubMedCrossRef McKinnon JG, Starritt EC, Scolyer RA, et al. Histopathologic excision margin affects local recurrence rate: analysis of 2681 patients with melanomas ≤2 mm thick. Ann Surg 2005;241:326–33PubMedCrossRef
8.
go back to reference Thompson JF, Scolyer RA, Uren RF. Surgical management of primary cutaneous melanoma: excision margins and the role of sentinel lymph node examination. Surg Oncol Clin N Am 2006;15:301–18PubMedCrossRef Thompson JF, Scolyer RA, Uren RF. Surgical management of primary cutaneous melanoma: excision margins and the role of sentinel lymph node examination. Surg Oncol Clin N Am 2006;15:301–18PubMedCrossRef
9.
go back to reference Lens MB, Dawes M, Goodacre T, et al. Excision margins in the treatment of primary cutaneous melanoma: a systematic review of randomized controlled trials comparing narrow vs wide excision. Arch Surg 2002;137:1101–6PubMedCrossRef Lens MB, Dawes M, Goodacre T, et al. Excision margins in the treatment of primary cutaneous melanoma: a systematic review of randomized controlled trials comparing narrow vs wide excision. Arch Surg 2002;137:1101–6PubMedCrossRef
10.
go back to reference Balch CM, Urist MM, Karakousis CP, et al. Efficacy of 2-cm surgical margins for intermediate-thickness melanomas (1 to 4 mm). Ann Surg 1993;218:262–9PubMedCrossRef Balch CM, Urist MM, Karakousis CP, et al. Efficacy of 2-cm surgical margins for intermediate-thickness melanomas (1 to 4 mm). Ann Surg 1993;218:262–9PubMedCrossRef
11.
go back to reference Hieken TJ. The role of sentinel node biopsy in skin cancer (2nd edition). In: eMedicine Clinical Knowledge Base, Dermatology. Updated May 2006. Available at: http://www.emedicine.com. Accessed March 1, 2007 Hieken TJ. The role of sentinel node biopsy in skin cancer (2nd edition). In: eMedicine Clinical Knowledge Base, Dermatology. Updated May 2006. Available at: http://​www.​emedicine.​com. Accessed March 1, 2007
12.
go back to reference Morton DL, Thompson JF, Cochran JF, et al. Sentinel-node biopsy or nodal observation in melanoma. N Engl J Med 2006;355:1307–15PubMedCrossRef Morton DL, Thompson JF, Cochran JF, et al. Sentinel-node biopsy or nodal observation in melanoma. N Engl J Med 2006;355:1307–15PubMedCrossRef
14.
go back to reference Haigh PI, Urbach DR. Underuse of wide excision for primary cutaneous melanoma in the United States. Am Surg 2004;70:942–6PubMed Haigh PI, Urbach DR. Underuse of wide excision for primary cutaneous melanoma in the United States. Am Surg 2004;70:942–6PubMed
15.
go back to reference Cormier JN, Xing Y, Ding M, et al. Population-based assessment of surgical treatment trends for patients with melanoma in the era of sentinel lymph node biopsy. J Clin Oncol 2005;23:6054–62PubMedCrossRef Cormier JN, Xing Y, Ding M, et al. Population-based assessment of surgical treatment trends for patients with melanoma in the era of sentinel lymph node biopsy. J Clin Oncol 2005;23:6054–62PubMedCrossRef
16.
go back to reference Sitzenberg KB, Thomas NE, Beskow LM, et al. Population-based analysis of lymphatic mapping and sentinel lymphadenectomy utilization for intermediate thickness melanoma. J Surg Oncol 2006;93:100–8CrossRef Sitzenberg KB, Thomas NE, Beskow LM, et al. Population-based analysis of lymphatic mapping and sentinel lymphadenectomy utilization for intermediate thickness melanoma. J Surg Oncol 2006;93:100–8CrossRef
17.
go back to reference Scott JD, McKinley BP, Bishop A, et al. Treatment and outcomes of melanoma with a Breslow’s depth greater than or equal to one millimeter in a regional teaching hospital. Am Surg 2005;71:198–201PubMed Scott JD, McKinley BP, Bishop A, et al. Treatment and outcomes of melanoma with a Breslow’s depth greater than or equal to one millimeter in a regional teaching hospital. Am Surg 2005;71:198–201PubMed
18.
go back to reference Lens MB, Dawes M. Global perspectives of contemporary epidemiological trends of cutaneous malignant melanoma. Br J Dermatol 2004;150:179–85PubMedCrossRef Lens MB, Dawes M. Global perspectives of contemporary epidemiological trends of cutaneous malignant melanoma. Br J Dermatol 2004;150:179–85PubMedCrossRef
Metadata
Title
Compliance with Melanoma Treatment Guidelines in a Community Teaching Hospital: Time Trends and Other Variables
Authors
Jennifer L. Erickson, MD
Josè M. Velasco, MD
Tina J. Hieken, MD
Publication date
01-04-2008
Publisher
Springer-Verlag
Published in
Annals of Surgical Oncology / Issue 4/2008
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-007-9789-6

Other articles of this Issue 4/2008

Annals of Surgical Oncology 4/2008 Go to the issue